Comparing Dayvigo vs Lunesta
| Dayvigo (lemborexant) | Lunesta (eszopiclone) |
|
|---|
| Dayvigo (lemborexant) | Lunesta (eszopiclone) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Insomnia. Dayvigo may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Insomnia. Lunesta may also be used for purposes not listed in this medication guide. |
Related suggestions Insomnia
|
|||||||||||||||
| More about Dayvigo (lemborexant) | More about Lunesta (eszopiclone) | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Dayvigo has an average rating of 5.1 out of 10 from a total of 271 ratings on Drugs.com. 42% of reviewers reported a positive effect, while 47% reported a negative effect. |
Lunesta has an average rating of 5.9 out of 10 from a total of 342 ratings on Drugs.com. 45% of reviewers reported a positive effect, while 35% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
View all Dayvigo side effects |
View all Lunesta side effects |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Generic Availability | |||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Dayvigo prices |
View all Lunesta prices |
||||||||||||||||
| Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
|
19 hours |
6 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
|
Some potential for abuse
Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3. |
Some potential for abuse
Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Summary unavailable. See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 464 drugs are known to interact with Dayvigo:
|
A total of 385 drugs are known to interact with Lunesta:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
|||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
December 20, 2019 |
December 15, 2004 |
||||||||||||||||
| WADA Class View classifications | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient Resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.